Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Morgan

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2003
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studiesBruno Morgan, Anne L Thomas, Joachim Drevs, et al.
Cancer Letters|May 17, 2015
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapyMark I James, Chinenye Iwuji, Glen Irving, et al.
Journal of Cardiovascular Computed Tomography|June 26, 2026
Non-invasive assessment of coronary inflammation improves the diagnostic accuracy of coronary death in post-mortem CT angiographyCheng Xie, Tina MacKinnon, Peter Cox, et al.
Nature Communications|August 21, 2024
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesotheliomaMin Zhang, Aleksandra Bzura, Essa Y Baitei, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Nature Reviews. Clinical Oncology|October 12, 2016
Imaging biomarker roadmap for cancer studiesJames P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2003
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studiesBruno Morgan, Anne L Thomas, Joachim Drevs, et al.
Cancer Letters|May 17, 2015
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapyMark I James, Chinenye Iwuji, Glen Irving, et al.
Journal of Cardiovascular Computed Tomography|June 26, 2026
Non-invasive assessment of coronary inflammation improves the diagnostic accuracy of coronary death in post-mortem CT angiographyCheng Xie, Tina MacKinnon, Peter Cox, et al.
Nature Communications|August 21, 2024
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesotheliomaMin Zhang, Aleksandra Bzura, Essa Y Baitei, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Nature Reviews. Clinical Oncology|October 12, 2016
Imaging biomarker roadmap for cancer studiesJames P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Pageof 7